| Code | CSB-RA614961A40phHU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
| IF | 1:20-1:200 |
NFE2L2, commonly known as NRF2, serves as the master regulator of the cellular antioxidant response, orchestrating the transcription of cytoprotective genes that defend against oxidative stress and electrophilic damage. Phosphorylation at serine 40 represents a critical activation event, releasing NFE2L2 from its cytoplasmic inhibitor KEAP1 and enabling nuclear translocation where it drives expression of detoxification enzymes and stress response proteins. This phosphorylation site has become increasingly important in cancer research, neurodegenerative disease studies, and investigations into cellular stress adaptation mechanisms.
This recombinant monoclonal antibody, generated from clone 2E6, offers the reproducibility and sequence-defined consistency that phospho-specific detection demands. Because phosphorylation events can be transient and context-dependent, having a reliable reagent that performs identically across experiments eliminates a significant source of variability in your signaling studies.
Validation across multiple platforms demonstrates genuine workflow flexibility. Western blot analysis confirms specific detection at the expected 90 kDa molecular weight in HepG2 and 293 cell lysates, with the latter treated with Calyculin A or EGF to enhance phosphorylation signals. Immunohistochemistry staining in paraffin-embedded human breast cancer tissue reveals clear detection using citrate buffer antigen retrieval, while immunofluorescence in HeLa cells shows the expected nuclear and cytoplasmic distribution pattern characteristic of NFE2L2 localization dynamics.
The unconjugated format and affinity-purified preparation provide compatibility with your preferred detection systems while maintaining low background. For researchers investigating oxidative stress responses, cancer metabolism, or the NFE2L2-KEAP1 pathway in epigenetics and nuclear signaling contexts, this antibody delivers the phospho-specific detection needed to track this pivotal regulatory modification.
There are currently no reviews for this product.